181 related articles for article (PubMed ID: 18952429)
1. Rigid spine syndrome caused by a novel mutation in four-and-a-half LIM domain 1 gene (FHL1).
Shalaby S; Hayashi YK; Goto K; Ogawa M; Nonaka I; Noguchi S; Nishino I
Neuromuscul Disord; 2008 Dec; 18(12):959-61. PubMed ID: 18952429
[TBL] [Abstract][Full Text] [Related]
2. Consequences of mutations within the C terminus of the FHL1 gene.
Schoser B; Goebel HH; Janisch I; Quasthoff S; Rother J; Bergmann M; Müller-Felber W; Windpassinger C
Neurology; 2009 Aug; 73(7):543-51. PubMed ID: 19687455
[TBL] [Abstract][Full Text] [Related]
3. Familial reducing body myopathy with cytoplasmic bodies and rigid spine revisited: identification of a second LIM domain mutation in FHL1.
Schessl J; Columbus A; Hu Y; Zou Y; Voit T; Goebel HH; Bönnemann CG
Neuropediatrics; 2010 Feb; 41(1):43-6. PubMed ID: 20571991
[TBL] [Abstract][Full Text] [Related]
4. Reducing body myopathy and other FHL1-related muscular disorders.
Schessl J; Feldkirchner S; Kubny C; Schoser B
Semin Pediatr Neurol; 2011 Dec; 18(4):257-63. PubMed ID: 22172421
[TBL] [Abstract][Full Text] [Related]
5. FHL1 mutants that cause clinically distinct human myopathies form protein aggregates and impair myoblast differentiation.
Wilding BR; McGrath MJ; Bonne G; Mitchell CA
J Cell Sci; 2014 May; 127(Pt 10):2269-81. PubMed ID: 24634512
[TBL] [Abstract][Full Text] [Related]
6. FHL1-related myopathy may not be classified by reducing bodies in muscle biopsy.
Chen T; Lu X; Shi Q; Guo J; Wang H; Wang Q; Yin X; Zhang Y; Pu C; Zhou D
Neuromuscul Disord; 2020 Feb; 30(2):165-172. PubMed ID: 32001145
[TBL] [Abstract][Full Text] [Related]
7. Novel FHL1 mutation in a family with reducing body myopathy.
Schreckenbach T; Henn W; Kress W; Roos A; Maschke M; Feiden W; Dillmann U; Schulz JB; Weis J; Claeys KG
Muscle Nerve; 2013 Jan; 47(1):127-34. PubMed ID: 23169582
[TBL] [Abstract][Full Text] [Related]
8. Four and a half LIM protein 1 gene mutations cause four distinct human myopathies: a comprehensive review of the clinical, histological and pathological features.
Cowling BS; Cottle DL; Wilding BR; D'Arcy CE; Mitchell CA; McGrath MJ
Neuromuscul Disord; 2011 Apr; 21(4):237-51. PubMed ID: 21310615
[TBL] [Abstract][Full Text] [Related]
9. Fhl1 W122S causes loss of protein function and late-onset mild myopathy.
Emmanuele V; Kubota A; Garcia-Diaz B; Garone C; Akman HO; Sánchez-Gutiérrez D; Escudero LM; Kariya S; Homma S; Tanji K; Quinzii CM; Hirano M
Hum Mol Genet; 2015 Feb; 24(3):714-26. PubMed ID: 25274776
[TBL] [Abstract][Full Text] [Related]
10. An X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1.
Windpassinger C; Schoser B; Straub V; Hochmeister S; Noor A; Lohberger B; Farra N; Petek E; Schwarzbraun T; Ofner L; Löscher WN; Wagner K; Lochmüller H; Vincent JB; Quasthoff S
Am J Hum Genet; 2008 Jan; 82(1):88-99. PubMed ID: 18179888
[TBL] [Abstract][Full Text] [Related]
11. Selective muscle involvement in a family affected by a second LIM domain mutation of fhl1: an imaging study using computed tomography.
Komagamine T; Kawai M; Kokubun N; Miyatake S; Ogata K; Hayashi YK; Nishino I; Hirata K
J Neurol Sci; 2012 Jul; 318(1-2):163-7. PubMed ID: 22541254
[TBL] [Abstract][Full Text] [Related]
12. X-linked Recessive Distal Myopathy With Hypertrophic Cardiomyopathy Caused by a Novel Mutation in the FHL1 Gene.
D'Arcy C; Kanellakis V; Forbes R; Wilding B; McGrath M; Howell K; Ryan M; McLean C
J Child Neurol; 2015 Aug; 30(9):1211-7. PubMed ID: 25246303
[TBL] [Abstract][Full Text] [Related]
13. A novel mutation in FHL1 in a family with X-linked scapuloperoneal myopathy: phenotypic spectrum and structural study of FHL1 mutations.
Chen DH; Raskind WH; Parson WW; Sonnen JA; Vu T; Zheng Y; Matsushita M; Wolff J; Lipe H; Bird TD
J Neurol Sci; 2010 Sep; 296(1-2):22-9. PubMed ID: 20633900
[TBL] [Abstract][Full Text] [Related]
14. Contractures and hypertrophic cardiomyopathy in a novel FHL1 mutation.
Knoblauch H; Geier C; Adams S; Budde B; Rudolph A; Zacharias U; Schulz-Menger J; Spuler A; Yaou RB; Nürnberg P; Voit T; Bonne G; Spuler S
Ann Neurol; 2010 Jan; 67(1):136-40. PubMed ID: 20186852
[TBL] [Abstract][Full Text] [Related]
15. Isolated X-linked hypertrophic cardiomyopathy caused by a novel mutation of the four-and-a-half LIM domain 1 gene.
Hartmannova H; Kubanek M; Sramko M; Piherova L; Noskova L; Hodanova K; Stranecky V; Pristoupilova A; Sovova J; Marek T; Maluskova J; Ridzon P; Kautzner J; Hulkova H; Kmoch S
Circ Cardiovasc Genet; 2013 Dec; 6(6):543-51. PubMed ID: 24114807
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic heterogeneity in British patients with a founder mutation in the FHL1 gene.
Sarkozy A; Windpassinger C; Hudson J; Dougan CF; Lecky B; Hilton-Jones D; Eagle M; Charlton R; Barresi R; Lochmüller H; Bushby K; Straub V
Eur J Hum Genet; 2011 Oct; 19(10):1038-44. PubMed ID: 21629301
[TBL] [Abstract][Full Text] [Related]
17. Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy.
Friedrich FW; Wilding BR; Reischmann S; Crocini C; Lang P; Charron P; Müller OJ; McGrath MJ; Vollert I; Hansen A; Linke WA; Hengstenberg C; Bonne G; Morner S; Wichter T; Madeira H; Arbustini E; Eschenhagen T; Mitchell CA; Isnard R; Carrier L
Hum Mol Genet; 2012 Jul; 21(14):3237-54. PubMed ID: 22523091
[TBL] [Abstract][Full Text] [Related]
18. Four and a half LIM domains 1 (FHL1) and receptor interacting protein of 140kDa (RIP140) interact and cooperate in estrogen signaling.
Lin J; Ding L; Jin R; Zhang H; Cheng L; Qin X; Chai J; Ye Q
Int J Biochem Cell Biol; 2009 Jul; 41(7):1613-8. PubMed ID: 19401155
[TBL] [Abstract][Full Text] [Related]
19. Clinical, histological and genetic characterization of reducing body myopathy caused by mutations in FHL1.
Schessl J; Taratuto AL; Sewry C; Battini R; Chin SS; Maiti B; Dubrovsky AL; Erro MG; Espada G; Robertella M; Saccoliti M; Olmos P; Bridges LR; Standring P; Hu Y; Zou Y; Swoboda KJ; Scavina M; Goebel HH; Mitchell CA; Flanigan KM; Muntoni F; Bönnemann CG
Brain; 2009 Feb; 132(Pt 2):452-64. PubMed ID: 19181672
[TBL] [Abstract][Full Text] [Related]
20. Identification of FHL1 as a regulator of skeletal muscle mass: implications for human myopathy.
Cowling BS; McGrath MJ; Nguyen MA; Cottle DL; Kee AJ; Brown S; Schessl J; Zou Y; Joya J; Bönnemann CG; Hardeman EC; Mitchell CA
J Cell Biol; 2008 Dec; 183(6):1033-48. PubMed ID: 19075112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
